Introduction {#section1-1753466619892492}
============

Worldwide, preterm birth is the leading cause of death in children less than 5 years of age, with approximately 10.6% of live births categorized as preterm (\<37 weeks gestation).^[@bibr1-1753466619892492]^ While the majority of preterm births occur in late gestation (between 34 and 37 weeks gestation), these children are at higher risk for respiratory morbidity compared with term infants. These respiratory morbidities include higher rates of respiratory distress in the neonatal period and diagnosis of asthma in adulthood.^[@bibr2-1753466619892492],[@bibr3-1753466619892492]^ However, few late-term premature infants go on to develop bronchopulmonary dysplasia (BPD).^[@bibr4-1753466619892492]^ Indeed, it is the very early gestational age infants (⩽32 weeks gestation) who are at highest risk for mortality, and who are most likely to develop BPD.^[@bibr5-1753466619892492][@bibr6-1753466619892492][@bibr7-1753466619892492]--[@bibr8-1753466619892492]^ Due to advances in the treatment of preterm birth, many more very low birthweight preterm infants are surviving to hospital discharge, contributing to the increase in children at risk for BPD development and respiratory morbidities in later life.^[@bibr9-1753466619892492],[@bibr10-1753466619892492]^

Survivors of prematurity are frequently burdened with a variety of complications, including respiratory disease. These respiratory complications can include pulmonary hypertension, asthma-like phenotypes, alveolar hypoplasia, obstructive sleep apnea, large airway malacia, and, most prominently, BPD, which can encompass one or more of these morbidities.^[@bibr11-1753466619892492]^ In the United States alone, it is estimated that nearly 50,000 preterm infants develop chronic lung disease due to their prematurity annually.^[@bibr11-1753466619892492]^ The disruption of alveolar growth associated with BPD may have lifelong consequences, including a possible link to early onset chronic obstructive pulmonary disease (COPD) in adult life. In this article, we will discuss the impact of prematurity on respiratory health, factors that contribute to the development of BPD, and the long-term consequences of BPD, particularly as they relate to COPD.

Respiratory health trajectories {#section2-1753466619892492}
===============================

A number of studies have demonstrated the existence of lung function trajectories where maximal lung function is achieved in early adulthood with a subsequent decline with aging.^[@bibr12-1753466619892492]^ However, considerable heterogeneity exist in the maximal lung function achieved and the rate of decline.^[@bibr12-1753466619892492]^ This heterogeneity in lung function trajectories is likely influenced in part by adverse prenatal and postnatal life events. Although the conducting airways are formed at the end of the pseudoglandular stage of fetal lung development, the lung is immature at birth with few alveoli.^[@bibr13-1753466619892492]^ The majority of postnatal alveolar growth occurs between birth and 8 years of age, with most alveolar growth occurring by 3 years of age.^[@bibr14-1753466619892492],[@bibr15-1753466619892492]^ Recently, however, studies have shown that some additional alveolar growth can occur through late adolescence and early adulthood.^[@bibr16-1753466619892492]^ Factors in early life that adversely affect respiratory growth can lead to heterogeneity in achieving maximal lung function. These events, with often seemingly normal recoveries, have been demonstrated to impair adult lung function. For example, a history of radiologically diagnosed pneumonia within the first 3 years of life has been associated with lower lung function in young adults, compared with their counterparts without such a history.^[@bibr17-1753466619892492]^ Lung function trajectories during life can be also be influenced by prenatal exposures, most notably exposure to tobacco smoke.^[@bibr18-1753466619892492]^ Exposure to tobacco smoke *in utero* has been associated with increased wheezing in preschool children, and is a major risk factor for BPD development in preterm infants exposed to maternal smoking during pregnancy.^[@bibr19-1753466619892492],[@bibr20-1753466619892492]^ Additionally, preclinical studies in mice confirm that disruption of lung growth during early postnatal life can adversely affect lung function in adult life.^[@bibr21-1753466619892492][@bibr22-1753466619892492]--[@bibr23-1753466619892492]^ Taken together, these preclinical and clinical studies suggest that prenatal and postnatal insults and exposures occurring during critical periods of lung growth are likely to impair lung function in later life.

From these studies, it is possible to surmise that premature birth and the development of BPD can have long-term effects on respiratory health, lung function, and, potentially, the development of COPD. Supporting this link between early life events and adult respiratory outcomes, Barker and colleagues reported that men born with low birth weights between 1911 and 1930, were more likely to have lower adult lung function and death from COPD.^[@bibr24-1753466619892492]^ In their report, the presence of lower respiratory tract infections was additive to the reduction of lung function in adult life. A recent literature review of 16 studies identified that preterm birth and low birth weight, in addition to *in utero* tobacco exposure, early childhood asthma, and pneumonia were factors that increased the likelihood of lung function impairment in late childhood.^[@bibr25-1753466619892492]^ Other studies have also reported that preterm birth is associated with respiratory limitations on exercise studies in older children and adults,^[@bibr26-1753466619892492][@bibr27-1753466619892492][@bibr28-1753466619892492]--[@bibr29-1753466619892492]^ and several studies have reported lower lung function in preterm infants with and without BPD compared with age-matched controls born at term.^[@bibr30-1753466619892492],[@bibr31-1753466619892492]^ Chest imaging of children with BPD has also demonstrated abnormalities of airflow obstruction. One study reported areas of hyperexpansion and hyperlucency in chest radiographic and computed tomography (CT) scans from children with a history of BPD.^[@bibr32-1753466619892492]^ Unlike imaging in COPD, however, studies are lacking on lung CT imaging scores and correlation with lung function and clinical symptoms in people with BPD.^[@bibr33-1753466619892492]^

The diagnosis of BPD and gestational age at birth has the greatest influence on later lung function in children with BPD.^[@bibr30-1753466619892492],[@bibr34-1753466619892492]^ Balinotti and colleagues, reported that infants and toddlers with a history of prematurity and chronic lung disease had impaired alveolar growth compared with full-term age-matched participants.^[@bibr35-1753466619892492]^ Another study reported that alveolar catch-up growth was achievable in older extremely low birth weight (ELBW) children (ages 10--14 years); however, the ELBW children had significantly lower FEV1 than the full-term controls.^[@bibr36-1753466619892492]^ It is not entirely understood why people with a history of ELBW with and without BPD have airflow obstruction; however, it is known that preterm infants have fewer and larger alveoli,^[@bibr37-1753466619892492]^ resulting in less lung surface area for gas exchange. It is plausible that fewer alveoli and alveolar attachments in the preterm lung causes less stenting open of small airways during a period of rapid postnatal lung growth, resulting in dysanaptic airway growth and fixed airflow obstruction, similar to airflow obstruction in COPD.^[@bibr38-1753466619892492]^

Worldwide, COPD is a leading cause of death in adults, with 3.2 million people dying of COPD in 2015.^[@bibr39-1753466619892492]^ Risk factors for developing COPD include cigarette smoking, indoor air pollution, diagnosis of asthma, and genetic risk factors. Similar to BPD, COPD is characterized by small airway disease and lower predicted forced expiratory volume in the first 1 s (FEV1 %).^[@bibr40-1753466619892492]^ People with COPD commonly present with shortness of breath, chronic cough, and mucus production, with declines in FEV1 triggered by upper respiratory tract infections.^[@bibr41-1753466619892492],[@bibr42-1753466619892492]^ Hallmarks of COPD progression, include an accelerated decline in FEV1 with age, radiographic evidence of emphysema, and end-stage lung disease. Disruption of normal lung development by preterm birth and other early life events,^[@bibr43-1753466619892492][@bibr44-1753466619892492]--[@bibr45-1753466619892492]^ likely increases an individual's risk of reaching a critical threshold of lung disease, and going on to develop COPD in early adult life.

Epidemiology and manifestations of BPD {#section3-1753466619892492}
======================================

Although a number of respiratory morbidities occur at higher rates in preterm infants compared with their full-term counterparts, the lung disease most associated with extreme prematurity is bronchopulmonary dysplasia (BPD).^[@bibr4-1753466619892492]^ Based on autopsy specimens, Northway and colleagues described key findings of BPD in 1967 as including alveolar emphysema, pulmonary arteriolar changes, and hypertrophy of airway smooth muscle and the right ventricle.^[@bibr46-1753466619892492]^ The disease has evolved since that time, with the advent of surfactant administration in the late 1980s and incremental improvements in ventilatory technologies and strategies. BPD in the postsurfactant era is characterized by hypoplasia of the alveoli and simplification of the pulmonary vasculature. Despite these advances, the incidence of BPD has increased over the past two decades,^[@bibr8-1753466619892492]^ due partially to increased survival of earlier gestational infants, but also in part to the absence of therapies that promote lung growth and attenuate inflammation and oxidative stress in the preterm lung.^[@bibr8-1753466619892492],[@bibr47-1753466619892492],[@bibr48-1753466619892492]^

In clinical practice, manifestations of BPD may include elements of gas exchange abnormalities (chronic respiratory failure or insufficiency with hypercarbia or hypoxia) associated with alveolar disease and asthma-like phenotypes (wheezing or coughing) associated with small airway disease. Pulmonary hypertension (PH) may be present in infants and children with BPD, and is most often associated with pulmonary vascular disease; however, left ventricular (LV) dysfunction, intracardiac shunts, persistent patent ductus arteriosus, and pulmonary venous stenosis may contribute to the severity and development of PH. Severity of respiratory disease in children with BPD may range from mild tachypnea to the need for home mechanical ventilation. Based on a commonly used definition for BPD from a NHLBI committee,^[@bibr49-1753466619892492]^ there may be as many as 48,000 preterm infants in the United States who develop BPD, of whom 12,000 may require home supplemental oxygen, and, an additional 200 home mechanical ventilation.^[@bibr11-1753466619892492]^

Owing to catch-up lung growth within the first 2 years of life, the majority of infants with BPD who are discharged on supplemental oxygen are weaned to room air by 12 months of age, and the median age of those on home mechanical ventilation being weaned off is 25 months.^[@bibr50-1753466619892492][@bibr51-1753466619892492][@bibr52-1753466619892492][@bibr53-1753466619892492][@bibr54-1753466619892492]--[@bibr55-1753466619892492]^ However, infants with BPD still remain at high risk for rehospitalization, up to 50% within the first 2 years of life, usually secondary to respiratory infections.^[@bibr56-1753466619892492]^ Diagnosis of BPD, severity of BPD during initial hospitalization and length of time requiring supplemental oxygen has been shown to be predictive of lung function abnormalities in school age children in several studies.^[@bibr57-1753466619892492],[@bibr58-1753466619892492]^

Pathophysiology of BPD {#section4-1753466619892492}
======================

BPD is a multifactorial disorder with a complex pathophysiology much like COPD. While preterm birth is the greatest risk factor for developing BPD, not every infant born prematurely will develop BPD, and, similarly, every smoker may not develop COPD. Risk factors for developing BPD in preterm infants include extremely low birth weight,^[@bibr4-1753466619892492],[@bibr59-1753466619892492]^ small for gestational age,^[@bibr60-1753466619892492],[@bibr61-1753466619892492]^ genetic/epigenetic factors, prenatal events such as exposure to maternal smoking,^[@bibr20-1753466619892492]^ events occurring within the initial neonatal intensive care unit (NICU) admission, and exposures occurring after initial discharge into childhood.^[@bibr62-1753466619892492]^ Exposures in the NICU that increase the likelihood of developing BPD include high oxygen concentrations, positive pressure ventilation, aspiration events, pneumonia, and sepsis.

Alveolar hypoplasia with paucity of pulmonary vessels is a predominant feature of the BPD lung, and is exacerbated by extreme prematurity and environmental factors.^[@bibr34-1753466619892492]^ Murine studies have shown that blocking VEGF-VEGF receptor signaling leads to alveolar hypoplasia and impaired capillary growth.^[@bibr63-1753466619892492],[@bibr64-1753466619892492]^ Another study reported downregulation of HIF and VEGF mRNA in lung of neonatal mice exposed to intermittent hypoxia and hyperoxia.^[@bibr65-1753466619892492]^ These studies indicate that disruption of angiogenesis and subsequently of pulmonary vasculature are major factors in the pathophysiology and development of BPD in the preterm lung. Preclinical studies have also demonstrated that lung inflammation and oxidative stress interrupt lung growth and repair in the lungs of infants with BPD.^[@bibr66-1753466619892492],[@bibr67-1753466619892492]^ Both clinical and preclinical investigations are ongoing on the efficacy of Vitamin A supplementation, use of donor human milk, supplementation with deferoxamine, and the paracrine effects of mesenchymal stem cells (MSCs) and exosomes to improve the inflammatory milieu of the neonatal lung and enhance lung growth.^[@bibr68-1753466619892492],[@bibr69-1753466619892492]^ Recent studies have also identified changes in the airway microbiome associated with the development of BPD. In particular, decreased Lactobacilli has been associated with BPD progression.^[@bibr70-1753466619892492]^ Although it is known that BPD is associated with alveolar hypoplasia, lung inflammation, and impaired angiogenesis, currently there are no therapies in clinical practice that can promote lung growth and improve injury repair in the neonatal lung. The contributions of genetics, epigenetics, prenatal, and postnatal factors to the pathophysiology of BPD will be addressed in further detail below.

Genetic factors in BPD and COPD {#section5-1753466619892492}
===============================

There is a heritability component in people who develop asthma and COPD.^[@bibr71-1753466619892492]^ In BPD, classic twin studies have also suggested that genetic effects account for 53--82% of the variance in the development of BPD.^[@bibr72-1753466619892492],[@bibr73-1753466619892492]^ However, no common polymorphisms have been identified between three genome-wide association studies of BPD patients,^[@bibr74-1753466619892492][@bibr75-1753466619892492]--[@bibr76-1753466619892492]^ nor have loci been identified in a large copy number variant study.^[@bibr77-1753466619892492]^ However, rare variant studies performed using exome sequencing suggest that populations with BPD may have an excess of rare variants in genes associated with host defense, extracellular matrix breakdown, collagen fibril organization, morphogenesis of embryonic epithelium, and regulation of Wnt signaling pathway.^[@bibr78-1753466619892492],[@bibr79-1753466619892492]^

In contrast to BPD, recent genome-wide association studies (GWAS) using meta-analyses and improved imputation in COPD and asthma populations has increased the number of identified SNPs causally associated with lung function and predictive of COPD and asthma.^[@bibr80-1753466619892492]^ It is possible that SNP variation associated with COPD has relevance to BPD and vice versa. In one example, alpha-1-antrypsin (A1AT) deficiency was identified and linked to early onset COPD in the 1960s. Deficient A1AT levels secondary to variants in the *SERPINA1* gene have been found to account for about 1--3% of cases of COPD.^[@bibr71-1753466619892492]^ A preclinical BPD study in baboons reported low levels of alpha-1-antitrypsin elastase inhibitory activity in airways of animals with severe but not mild BPD.^[@bibr81-1753466619892492]^ However, whether a relationship exists between A1AT and BPD is not clearly known at this time.

In general, it is not known whether any specific asthma or COPD gene variants are more likely to be present in children with BPD, particularly severe BPD. Preclinical studies in mice support a relationship between certain gene variants and susceptibility to COPD-like phenotypes, particularly when augmented by exposure to tobacco smoke.^[@bibr82-1753466619892492][@bibr83-1753466619892492]--[@bibr84-1753466619892492]^ In humans, gene variants in the *HIP* gene have been associated with an increased risk of COPD, depending on pack-years of smoking exposure.^[@bibr85-1753466619892492]^ The *HIP* gene is in the Hedgehog signaling pathway, which plays a role in early lung development and injury responses. Taken together, human and preclinical studies indicate that certain genetic susceptibility factors may exist that increase the likelihood of chronic lung disease in individuals exposed to environmental or adverse insults such as tobacco smoke or preterm birth. Using meta-analyses and improved imputation of genome-wide association studies may help to identify more SNPs causally related to BPD phenotype and lung function. Identification of SNPs in BPD will help to identify critical alleles and provide mechanistic insights into disease severity and progression in BPD, and potentially have relevance for COPD.

Epigenetic and other factors in BPD {#section6-1753466619892492}
===================================

Epigenetic changes (DNA methylation) have been reported between the preterm and term human lung, but it is unclear whether these changes reflect cause or effect with regards to the development of BPD.^[@bibr86-1753466619892492]^ Intriguingly, preterm infants who develop BPD have differential gene expression in the chromatin remodeling pathway on umbilical cord samples compared with their preterm counterparts who did not develop BPD.^[@bibr87-1753466619892492]^ Sex differences in the development of BPD in preterm infants has been widely reported with males having a higher prevalence, which may be secondary to later surfactant production in males.^[@bibr88-1753466619892492]^ Race/ethnicity may also influence respiratory symptoms in preschool children born prematurely. Although Black race has been noted to be associated with a lower risk of BPD,^[@bibr89-1753466619892492]^ Wai and colleagues reported that maternal Black race was associated with an increased odds ratio of 2.9 of persistent wheeze in former extremely low birth weight preschool children.^[@bibr90-1753466619892492]^ Telomere length has not been found to be associated with a history of BPD in blood samples from 10-year-old children or adolescent salivary samples, but was associated with abnormal airflow.^[@bibr91-1753466619892492],[@bibr92-1753466619892492]^

Prenatal influences on BPD {#section7-1753466619892492}
==========================

Early life events affecting respiratory health can include factors that impact fetal development prior to birth. Prenatally, inflammatory stimuli may increase the risk for developing BPD after birth. These exposures may include *Ureaplasma* spp. infection and maternal smoking,^[@bibr20-1753466619892492],[@bibr93-1753466619892492]^ although the role of maternal chorioamnionitis in the development of BPD is more controversial.^[@bibr94-1753466619892492]^ Additionally, factors leading to reduced birth weight for a given gestational age also increase the risk for developing BPD, such as *intrauterine growth restriction* (IUGR) or multiple gestation.^[@bibr94-1753466619892492]^

Neonatal influences on BPD {#section8-1753466619892492}
==========================

After birth, the NICU is a complex set of exposures for the developing lung. Preclinical studies have been used to identify exposures and mechanisms that can impair alveolar growth and injury repair in preterm infants.^[@bibr95-1753466619892492][@bibr96-1753466619892492][@bibr97-1753466619892492][@bibr98-1753466619892492]--[@bibr99-1753466619892492]^ Unfortunately many of the therapies intended to aid these infants and improve survival can have unintended consequences for the lungs. The use of ventilators can lead to barotrauma or volutrauma,^[@bibr100-1753466619892492]^ need for intubation and prolonged NICU stays can be a risk factor for lower respiratory infections,^[@bibr101-1753466619892492],[@bibr102-1753466619892492]^ enteral feeds to prime the gut carries a risk of aspiration,^[@bibr103-1753466619892492],[@bibr104-1753466619892492]^ and the relative hyperoxia of even room air compared with hypoxic *in utero* conditions can lead to free radical injury.^[@bibr105-1753466619892492],[@bibr106-1753466619892492]^ Newer interventions, including avoidance of intubation and use of noninvasive ventilation and less invasive surfactant administration, are currently being implemented in an attempt to mitigate harm in extremely preterm infants.^[@bibr107-1753466619892492],[@bibr108-1753466619892492]^

Early childhood influences on BPD {#section9-1753466619892492}
=================================

While the majority of alveolarization occurs within the first 2 years of life, evidence exists that ongoing alveolarization can occur in 10- to 14-year-old children with a history of prematurity, ^[@bibr14-1753466619892492],[@bibr36-1753466619892492]^ thus suggesting that events even as late as early adolescence can affect long-term trajectories. Overall, it is likely that the additive effects of prematurity and early life respiratory insults/exposures disproportionately impact short- and long-term respiratory health and function in children diagnosed with BPD.

Following discharge from the NICU, it is probable that certain environmental exposures may lead to slower resolution or incomplete resolution of alveolar disease (and a reduction in adult lung function), potentially through increased inflammation.^[@bibr109-1753466619892492]^ For preterm infants and young children with BPD, the most significant source of inflammation is respiratory tract infections, which are also the most significant source of respiratory morbidity in infancy and early childhood.^[@bibr110-1753466619892492],[@bibr111-1753466619892492]^ Premature infants have been reported to have significant respiratory morbidities from even the common cold virus: rhinovirus.^[@bibr112-1753466619892492],[@bibr113-1753466619892492]^ The mechanism for common respiratory viruses during early postnatal life resulting in severe lower respiratory tract illnesses for infants and young children with BPD may be the immature immune system associated with preterm birth.^[@bibr114-1753466619892492],[@bibr115-1753466619892492]^ In addition to the immaturity of the immune system, some therapies employed to aid with respiratory disease can also worsen immune function. Preclinical studies have reported that neonatal hyperoxia can alter the lung's immune responses in adult mice both at baseline and when challenged with influenza or bleomycin.^[@bibr116-1753466619892492][@bibr117-1753466619892492][@bibr118-1753466619892492]--[@bibr119-1753466619892492]^ In addition, exposure to respiratory virus and the subsequent host inflammatory response may influence trajectory of lung function in children with BPD and induce airway reactivity in susceptible individuals. Associations have been reported with early life wheezing from rhinovirus and development of asthma.^[@bibr120-1753466619892492]^ It is plausible that exposure to rhinovirus and other respiratory viruses during infancy and early childhood could contribute to the airflow obstruction present in children and adults born preterm, especially those with BPD. Even within the BPD population, certain infants may be at higher risk for respiratory infections; two studies found that infants and children (\<3 years old) with BPD who attended daycare had more frequent respiratory symptoms and lower respiratory tract infections and greater acute healthcare usage than those who did not attend.^[@bibr121-1753466619892492],[@bibr122-1753466619892492]^ Overall, the evidence would suggest that early infections in combination with an underdeveloped preterm lung may contribute to lasting abnormalities in adult lung function, but it is not clear whether these potent effects continue into later adult life with development of COPD.

In addition to respiratory infections, there are other exposures that can induce inflammatory changes in the developing lung, which include secondhand smoke, recurrent aspiration, air pollution, or animal exposure.^[@bibr17-1753466619892492],[@bibr123-1753466619892492][@bibr124-1753466619892492]--[@bibr125-1753466619892492]^ Higher hair nicotine levels in preschool children with moderate to severe BPD were associated with more hospitalizations and greater activity limitations compared with children with lower or undetectable hair nicotine levels.^[@bibr126-1753466619892492]^ Another study found that maternal smoking was a strong predictor of reduced airflow and poorer respiratory function in young adults with BPD compared with controls.^[@bibr127-1753466619892492]^ Although the link between air pollution and BPD has not been studied, it is plausible to assume that air pollution may be a risk factor for decline in lung function in young adults with BPD, as a large study from the United Kingdom found that ambient air pollution was associated with higher prevalence of COPD.^[@bibr128-1753466619892492]^ Other exposures, including early exposures to cats and dogs, may influence long-term Th1 and Th2 inflammatory responses to environmental and infectious pulmonary insults in children with BPD.

In addition to inflammatory stimuli, nutritional factors may also affect the developing lung. Preterm infants with BPD are at increased risk for growth failure,^[@bibr129-1753466619892492]^ and animal studies suggest that malnutrition can negatively impact alveolarization.^[@bibr130-1753466619892492],[@bibr131-1753466619892492]^ However, limited spirometric data from children who were malnourished in early childhood \[reduced FEV~1~ and forced vital capacity (FVC) with preserved FEV~1~/FVC ratios\] have led to the hypothesis of 'lung-sparing growth', where lung development is spared compared with other organs.^[@bibr129-1753466619892492],[@bibr132-1753466619892492]^ Several factors may also mitigate the effect of BPD on respiratory morbidities. For instance, breast milk administration beyond 6 months of age was associated with a reduced likelihood of acute and chronic respiratory morbidities compared with BPD infants who did not receive breast milk beyond 6 months of age, and adherence to prescribed respiratory medications was also associated with better respiratory outcomes in children with BPD.^[@bibr133-1753466619892492],[@bibr134-1753466619892492]^ Based on these studies and extrapolation from non-BPD studies, there appears to be modifiable risk factors that can positively or negatively affect respiratory symptoms and lung function in children with BPD, which, in turn, may influence the development of COPD in this population ([Table 1](#table1-1753466619892492){ref-type="table"}).

###### 

Risk factors across development that can positively or negatively affect respiratory symptoms and lung function in children with BPD.

![](10.1177_1753466619892492-table1)

                                        Developmental stages and conditions that may influence adult lung function           
  ------------------------------------- ---------------------------------------------------------------------------- --- --- ---
  **Gestational**                                                                                                            
   Intrauterine growth restriction      x                                                                            x       
   Fetal exposure to maternal smoking   x                                                                            x   x   x
   Genetic conditions and mutations     x                                                                            x   x   x
  **Infancy**                                                                                                                
   Prematurity                                                                                                       x   x   x
   Bronchopulmonary dysplasia                                                                                        x   x   x
   Infant wheezing                                                                                                   x   x   x
   Pneumonia                                                                                                         x   x   x
   Secondhand smoke                                                                                                  x   x   x
   Genetic conditions and mutations                                                                                  x   x   x
   Nutrition                                                                                                         x   x   x
  **Childhood**                                                                                                              
   Asthma                                                                                                                x   x
   Secondhand smoke/air pollution                                                                                        x   x
   Allergic diseases                                                                                                     x   x
   COPD susceptibility genes                                                                                             x   x
  **Adolescence**                                                                                                            
   Primary smoking                                                                                                           x
   COPD susceptibility genes                                                                                                 x
   Secondhand smoke/air pollution                                                                                            x

BPD, bronchopulmonary dysplasia; COPD, chronic obstructive pulmonary disease.

Respiratory phenotypes in older children with BPD {#section10-1753466619892492}
=================================================

In children with BPD, obstructive lung disease (asthma-like phenotypes) may persist into adulthood,^[@bibr135-1753466619892492],[@bibr136-1753466619892492]^ which is frequently demonstrated through lower spirometric values.^[@bibr44-1753466619892492]^ While preterm survivors with BPD have been shown to have significantly lower *z*-scores for FEV~1~ compared with preterm survivors without BPD,^[@bibr137-1753466619892492]^ extreme prematurity alone can result in reduced airflow in young adults compared with term controls.^[@bibr26-1753466619892492]^ Respiratory phenotypes in older children are not limited to obstructive lung disease. Although not as common, restrictive lung disease can also be present in children with BPD.^[@bibr138-1753466619892492]^ A 2016 study that included young adults with BPD, a history of prematurity without BPD, and full-term control subjects, observed a higher likelihood of fixed airway obstruction and higher HRCT scan severity scores in the group with BPD compared with the other two groups, in addition to lower spirometric values.^[@bibr139-1753466619892492]^ In the same study, both groups of preterm infants had a greater reduction in gas transfer (KCO % predicted) and exercise study impairment compared with full-term controls. Chronic lung injury may also impair airway clearance in people with a history of BPD. Two studies that included school age children and young adults with a history of BPD reported that both age groups had impaired lung clearance indexes compared with age-matched controls.^[@bibr139-1753466619892492],[@bibr140-1753466619892492]^ Reported respiratory symptoms are also more frequent in adults with a previous history of BPD. For example, Caskey and colleagues studied 25 young adult survivors of BPD, and found that they were significantly more likely to wake up coughing, or be breathless with wheezing, compared with controls. Certain school-age children with BPD may be at higher risk for respiratory morbidities in adult life, including those with abnormal lung function and parenchymal changes on lung imaging. The structural and functional changes in the BPD lung can resemble that of an individual with COPD ([Figure 1](#fig1-1753466619892492){ref-type="fig"}). Risk stratification that includes prenatal and NICU history, postinitial hospitalization respiratory symptoms, environmental exposures, acute health care usage, lung imaging, and longitudinal lung function trajectories may be useful in identifying children with BPD at higher risk for early onset COPD.

![Lung function and imaging from an 8-year-old child with a history of severe BPD and an adult with COPD. (a) Emphysematous changes on a chest CT from child with BPD; (b) Spirometry showing mixed restrictive and obstructive lung disease from child with BPD; (c) Emphysematous changes on chest CT from adult with COPD; and (d) Spirometry showing severe obstructive lung disease from adult with COPD.\
BPD, bronchopulmonary dysplasia; COPD, chronic obstructive pulmonary disease; CT, computed tomography.](10.1177_1753466619892492-fig1){#fig1-1753466619892492}

Link between BPD and COPD {#section11-1753466619892492}
=========================

COPD is the fourth leading cause of death worldwide, and accounts for over 3 million deaths a year.^[@bibr141-1753466619892492]^ It is well known that environmental and genetic causes contribute to disease development and phenotype expression in COPD. Less is known, however, regarding the impact of early life events that contribute to COPD development in adult life. Premature delivery and BPD can alter the trajectory of normal lung growth during childhood. Indeed, a longitudinal study of a cohort of extremely low birth weight children born in Japan found that these children exhibited a significant decline in lung function between the ages of 8 and 12 years in both FEV~1~ % predicted and the FEV~1~/FVC ratio.^[@bibr40-1753466619892492]^ In a meta-analysis of 59 studies that included lung function on preterm and term subjects, Kotecha and colleagues found that the preterm subjects with a diagnosis of BPD had a 18.95% decrease in FEV1 compared with term controls.^[@bibr44-1753466619892492]^ Lower lung function in children with BPD may be associated with lower lung function in adult life, increasing the likelihood of COPD. This is supported by several longitudinal studies that found a correlation between childhood lung function and lung function trajectory in adult life.^[@bibr18-1753466619892492],[@bibr142-1753466619892492]^ Bui and colleagues found that lowest quartile of FEV~1~/FVC ratio at 7 years of age was associated with asthma-COPD overlap syndrome and COPD at 45 years of age.^[@bibr143-1753466619892492]^

Similar to asthma, the BPD lung is characterized by functional abnormalities in FEV~1~, FEV~1~/FVC ratio, and air trapping. Although mild-to-moderate persistent asthma in childhood has been linked to COPD,^[@bibr142-1753466619892492]^ the underlying pathophysiology for functional changes in the BPD lung likely differs from that of asthma. For instance, children with allergic asthma commonly have elevated levels of fractional exhaled nitric oxide (FENO), indicative of eosinophilic inflammation, whereas preterm children (with or without BPD) have been shown to have normal FENO values.^[@bibr144-1753466619892492]^ It is also believed that the BPD lung is characterized by impaired alveolar development leading to obstructive lung disease, in part through dysanaptic airway growth and airway inflammation.^[@bibr38-1753466619892492]^ In addition, children with BPD who are hospitalized for treatment of common respiratory viruses early in life have been shown to have worse lung function in later childhood.^[@bibr145-1753466619892492],[@bibr146-1753466619892492]^ Whether this is cause and effect or due to more severe BPD at the onset is unclear, but, nevertheless, it may contribute in an additive way to worse lung function in adult life and a greater propensity to develop COPD. Further studies are also needed to determine if variability in BPD lung phenotype is influenced by differential DNA injury repair and inflammatory responses to infectious and environmental insults that may increase the likelihood of COPD in adult life.

Lastly, it is unknown whether impaired alveolar growth, abnormal lung injury repair, and oxidative stress during early life can predispose the lung to premature aging, although this is currently being explored.^[@bibr147-1753466619892492]^ Reduced recruitment of endothelial progenitor cells from the bone marrow has been reported in neonatal mice exposed to hyperoxia.^[@bibr148-1753466619892492]^ However, although oxidative stress is associated with premature aging there is currently no evidence to indicate that BPD is associated with accelerated aging of the lung.^[@bibr149-1753466619892492]^

Conclusions and gaps in knowledge {#section12-1753466619892492}
=================================

Taken together, disrupted lung development, genetic susceptibility and subsequent environment and infectious events that occur during critical periods of postnatal lung development likely increase the predisposition of children with BPD to develop early onset COPD. With advances in neonatal care there will continue to be a greater number of extremely low birth-weight infants surviving to hospital discharge. Understanding variability in BPD outcomes that can occur in different geographic areas and from different NICUs is needed to identify optimal treatments.^[@bibr150-1753466619892492]^ As such, there is a need to identify those individuals born premature who are at greatest risk for developing long-term lung pathology due to their BPD, and those who will go on to develop COPD. As with COPD stratification, lung CT imaging scores to determine correlation with lung function and clinical symptoms in people with BPD may be useful in BPD. Studies that examine the link between upper respiratory tract viral exacerbations in later life and correlation with lung trajectories in people born preterm with BPD may also help identify subsets of children at highest risk for developing COPD. The role of early nutritional interventions and weight on long-term respiratory outcomes in preterm infants with BPD should be investigated along with guidelines for long-term follow up of preterm individuals with BPD to monitor lung function values and treatments of these individuals after they leave the NICU, ideally through establishment of prospective birth cohorts. Ultimately, large prospective observational studies in children with BPD are needed to more clearly understand and identify risk factors associated with COPD development in adult life.
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